Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trading with a market value of 1.83B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Fundamentals That Matter
It’s generally a good idea to start […]
Full Post at eglobalist.com